1. Essential medicines and human rights: what can they learn from each other?;Hogerzeil;Bull WHO,2006
2. The concept of essential medicines: lessons for rich countries;Hogerzeil;BMJ,2004
3. WHO Guideline on Country Pharmaceutical Pricing Policies;Geneva, Switzerland: WHO,2013
4. Bouvy J, Vogler S. Background paper 8.3. Pricing and reimbursement policies: impacts on innovation. In: World Health Organization, ed., Priority Medicines for Europe and the World “A Public Health Approach to Innovation” Update on 2004 Background Paper. Geneva, Switzerland: WHO, 2013.
5. European Commission DG Health & Consumers. High Level Pharmaceutical Forum. High Level Pharmaceutical Forum 2005-2008: Conclusions and Recommendations. Brussels, Belgium: European Commission, 2008.